• Title/Summary/Keyword: essential drugs

Search Result 243, Processing Time 0.023 seconds

Problems of Legal Permissible Limit in Metal Level of Herbal Drugs Using Current Korea (현행 한국의 한약재 중금속기준개정 필요성 고찰)

  • Lee Sun-Dong;Park Kyung-Sik
    • Journal of Society of Preventive Korean Medicine
    • /
    • v.5 no.1
    • /
    • pp.31-40
    • /
    • 2001
  • Legal permissible limit of herbal drugs metal level in Korea is define 'less 30.0ppm in total(except mineral drugs)' including Pb Hg Cd As Cr Ni etc. This limit has a lot of problems in several factors, that is, not divide hazard and essential elements, not consider high and low toxic effect in each metal, not calculate dose-response relationship and average health behavior in Korean etc. As a that result, It has strong limits and weakness in the basic toxicology and Oriental medicine. To improve and correct these factors, We need to several new approach as like below. It must be radical study following problems in short and middle-long period in the future, toxic metal and essential element must be divide to basic toxicology and also be diverse toxic effect. But mineral drugs that included a amount of severe toxic metals is being used as active prescription drug until now. If toxic, safety and side-effect of metals will be considered, mineral drugs must prohibit instantly or use at least after examined toxic effect. But one of the most important things about herbal drugs contamination, all people and department (government, farmer and trader, oriental medicine doctors and association) will be participate cooperative and collection for preventive or the least contamination in herbal drugs.

  • PDF

METHODS FOR ASSESSMENT OF GASTROINTESTINAL DRUG ACTIONS

  • Burks, Thomas F.
    • Proceedings of the Korean Society of Applied Pharmacology
    • /
    • 1994.04a
    • /
    • pp.113-125
    • /
    • 1994
  • Many types of drugs affect functions of tile gastrointestinal tract. Investigators may be interested in discovery or pharmacological characterization of drugs as therapeutic agents intended for treatment of gastrointestinal disorders or in identification of gastrointestinal side effects of drugs intended for non-gastrointestinal indications. Examples of drug categories often associated with significant gastrointestinal side effects include cardiovascular drugs, antibiotics (erythromycin in particular), anti-inflammatory drugs, antiemetics, analgesics (especially opiates), antihistamines, antidepressants, and antipsychotics. Whether tile objective is development of gastrointestinal therapeutic agents or evaluation of gastrointestinal side effects, appropriate laboratory models for experimentation are essential.

  • PDF

A Perspective on Pharmaceutical Industrial Research on Antihypertensive drugs

  • Lee, Jang-Yun;John F. DeBernardis
    • Archives of Pharmacal Research
    • /
    • v.10 no.4
    • /
    • pp.245-249
    • /
    • 1987
  • Cardiovascular disease is at present the leading cause of deth in the United States and other in dustrilized countries. A major contributing factor of cardiovascular disease is essential hypertension. Untreated, essential hypertension is considered a risk factor for sudden death due to myocardial infarctions, as well as a risk factor for cerebral vascular disease, renal failure and congestive heart failure. During the last decade, significant progress has been made in the basic knowledge of the pathogenesis of hypertension as well as in the development of new antihypertensive drugs.

  • PDF

Analysis of Current Status and Drug Expenditure of Drug Shortage Prevention Program (퇴장방지의약품관리제도의 운영 현황과 약품비 분석)

  • Chae, Su-Mi;Lee, Eui-Kyung
    • YAKHAK HOEJI
    • /
    • v.52 no.2
    • /
    • pp.160-164
    • /
    • 2008
  • This study investigated the current status and drug expenditure of the drug shortage prevention program in Korea. National health insurance claims data from 2001 to 2005 were analyzed for the drugs with inadequate supply, which were designated as shortage prevention drugs (SPDs). Drug use of SPDs have increased every year, but the average increase rate of drug expenditure for SPDs, 13.5% was lower than that for all the reimbursed drugs, 18.6%. Drugs with price increase based on production cost were more actively used than drugs with prescription incentives for doctors.

Development of New Antitumor Drugs from Natural Sources , with Guida (항종양활성 Screening을 지표로 한 천연물의약품의 개발연구와 그 생약소재의 품질평가에 대하여(抗腫瘍活性スクリ-ニングを指標とした天然物醫藥品の開發硏究とその生約素材の品質評價について))

  • Takeya, Koichi
    • Proceedings of the Plant Resources Society of Korea Conference
    • /
    • 1993.08a
    • /
    • pp.14-20
    • /
    • 1993
  • We in anticancer drug development from natural resources have conceived and used a wide variety of experimental screening systems to support our efforts during the past 20 tears. Screens have been devided to address targets at the molecular, biochemical and cellular levels, both in vivo and in vitro. Screens have been essential for the experimental evaluation of the products from natural sources. In this congress, antitumor screening methods for deveol[ment of new drugs from natural sources and evaluation of their crude drugs are discussed.

  • PDF

The worldwide trend of using botanical drugs and strategies for developing global drugs

  • Ahn, Kyungseop
    • BMB Reports
    • /
    • v.50 no.3
    • /
    • pp.111-116
    • /
    • 2017
  • Natural product drugs, or botanical drugs, are drugs composed of natural substances which have constituents with healthenhancing or medicinal activities. In Korea, government-led projects brought attention to botanical drugs invigorating domestic botanical drug industry. Foreign markets, as well, are growing bigger as the significance of botanical drugs stood out. To follow along with the tendency, Korea puts a lot of effort on developing botanical drugs suitable for global market. However, standards for approving drug sales vary by countries. And also, thorough standardization, certification, clinical studies and data of these will be required as well as data confirming safety and effectiveness. Meanwhile, as an international exchange in botanical drug market continues, the importance of plant resources was emphasized. Thus countries' ownership of domestic natural resources became vital. Not only establishing a systematic method to secure domestic plant resources, but also cooperation with other countries on sharing natural resources is essential to procure natural resources effectively. Korea started to show visible results with botanical drugs, and asthma/COPD treatment made out of speedwell is one example. Sufficient investment and government's active support for basic infrastructure for global botanical drugs will bring Korea to much higher level of botanical drug development.

The Screening of Antibiotics Resistance Inhibition of Herb Drugs entered in Korean Official Formulary (II) - Resistance Inhibition of 36 Essential Oils - (공정서 수재생약 정유의 항생제 내성억제작용 검색 (II) - 36종 정유의 내성억제작용 -)

  • Kim, Dong-Myeong;Heo, Kyung-Hee;Moon, Kyung-Ho;Lee, Chung-Kyu
    • Korean Journal of Pharmacognosy
    • /
    • v.40 no.1
    • /
    • pp.70-76
    • /
    • 2009
  • Thirty six essential oils from herb drugs entered in Korean official formulary, which are frequently used in oriental region, were tested for antibiotic resistance inhibition. When the oils were combined with ampicillin (Am) or amoxicillin (Amx) they showed significant inhibitory effects on the growth of multi-drug resistant Staphylococcus aureus SA2 in considerably low concentration. The most effective combinations were oils from Acanthopanacis Cortex ($0.49{\mu}g/mL$) with Am and Cnidii Rhizoma and Lonicerae Flos (2.77 and $2.79{\mu}g/mL$, respectively) with Amx as shown in minimum resistance inhibitory concentrations.

A Survey of Pharmacy Students' Perceptions of National Drug Supply Strategy through Public Pharmaceutical Companies (약학대학 학생들의 공공제약사를 통한 국가의 의약품공급 전략에 대한 인식 조사)

  • Jeon, Sung Ryul;Ha, Jung Eun;Sohn, Hyun Soon
    • Korean Journal of Clinical Pharmacy
    • /
    • v.27 no.4
    • /
    • pp.238-249
    • /
    • 2017
  • Background: Currently establishment of public pharmaceutical companies became an issue for securing stable supply of national essential drugs in order to respond appropriately to national public health crisis. Pharmacy students as future pharmacists need to be interested in drug related issues under the discussion in our society. This study aimed to investigate perceptions of pharmacy students on the national drug supply strategy through public pharmaceutical companies. Methods: A 20-items questionnaire designed for this study was used. Pharmacy students nationwide were enrolled in July 2017. They responded to questions through on-line survey program. Data were analyzed descriptively. Results: 160 students from 26 pharmacy schools participated. 5th and 6th grade students accounted for two-thirds, and one third aspired future jobs in pharmaceutical industry. Among responders, 71.3% was unaware of current national essential drugs, 52.5% did not know the Rare and Essential Drug Center, and 91.9% was unaware of the legislation on the supply and management of essential drugs. 82.5% favored the establishment of public pharmaceutical companies. 80.6% agreed that government should intervene in pharmaceutical market for ensuring drug accessibilities, 73.8% agreed that public pharmaceutical companies make possible to reach a goal of stable supply of pharmaceuticals, and 85.1% agreed that active compulsory license by public pharmaceutical companies is necessary. Conclusion: We found that pharmacy students recognized the need for governmental control to achieve social values of pharmaceuticals. More attention and participation of the pharmacy students as well as pharmacists in the process of national debate on public pharmaceutical companies are expected.

Comparative Study on the Botanical Origin of Crude Drugs in Official Compendia of Korea, China and Japan (한국·중국·일본 세 나라 공정서수재 생약의 기원 비교연구)

  • Park, Woo Sung;Kim, Hye-Jin;Ahn, Mi-Jeong
    • Korean Journal of Pharmacognosy
    • /
    • v.48 no.4
    • /
    • pp.350-358
    • /
    • 2017
  • It is an essential prerequisite to use exact botanical origin of crude drugs for a therapeutic effect. The botanical origin also affects the standard for quality control. During the past decades, Korea, China and Japan have developed individually their own official compendia for crude drugs to tune with the times. This study was accomplished to offer basic data and appropriate suggestions to rebuilding the botanical origins of crude drugs in Korean official compendia according to international harmonization. For this, the botanical origin of crude drugs in official compendia of these three countries were compared based on the scientific name internationally accepted. As results, there were five crude drugs defined as plants or animal of which family were different. Fourteen crude drugs showed the botanical origin of different genus and eighty eight of different species. In addition, usage part and collection season differed in twelve and four crude drugs, respectively.